Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

References

• KesslerRCChiuWTDemlerOMerikangasKRWaltersEEPrevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry20056261762715939839
   PubMed Web of Science ®Google Scholar
• World Health OrganizationThe World Health Report 2004: Changing History, Annex Table 3: Burden of disease in DALYs by cause, sex, and mortality stratum in WHO regions, estimates for 2002World Health OrganizationGeneva, Switzerland2004
   Google Scholar
• GreenbergPEKesslerRCBirnbaumHGThe economic burden of depression in the United States: how did it change between 1990 and 2000?J Clin Psychiatry2003641465147514728109
   PubMed Web of Science ®Google Scholar
• StaffordRSMacDonaldEAFinkelsteinSNNational Patterns of Medication Treatment for Depression, 1987 to 2001Prim Care Companion J Clin Psychiatry2001323223515014590
   PubMedGoogle Scholar
• CaleyCFKandoJCSSRI efficacy-finding the right doseJ Psychiatr Pract20028334015985852
   PubMedGoogle Scholar
• CantrellCREaddyMTShahMBReganTSSokolMCMethods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomesMed Care20064430030316565629
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionValue Health200811444718237359
   PubMed Web of Science ®Google Scholar
• RuhéHGHuyserJSwinkelsJAScheneAHSwitching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic reviewJ Clin Psychiatry2006671836185517194261
   PubMed Web of Science ®Google Scholar
• KhandkerRKKruzikasDTMcLaughlinTPPharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorderJ Manag Care Pharm20081442644118597572
   PubMed Web of Science ®Google Scholar
• MelfiCAChawlaAJCroghanTWHannaMPKennedySSredlKThe effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depressionArch Gen Psychiatry199855112811329862557
   PubMed Web of Science ®Google Scholar
• LinEHVon KorffMBushTSimonGEWalkerERobinsonPThe role of the primary care physician in patients’ adherence to antidepressant therapyMed Care19953367747823648
   PubMed Web of Science ®Google Scholar
• EaddyMTDrussBGSarnesMWReganTSFrankumLERelationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy: results from a managed care administrative claims databaseJ Manag Care Pharm20051114515015766321
   PubMedGoogle Scholar
• NantzELiu-SeifertHSkljarevskiVPredictors of premature discontinuation of treatment in multiple disease statesPatient Prefer Adherence20093314319936143
   PubMed Web of Science ®Google Scholar
• BosworthHBVoilsCIPotterGGSteffensDCThe effects of anti-depressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adultsInt J Geriatr Psychiatry2008312913417563920
   PubMed Web of Science ®Google Scholar
• BullochAGPattenSBNon-adherence with psychotropic medications in the general populationSoc Psychiatry Psychiatr Epidemiol201045475619347238
   PubMed Web of Science ®Google Scholar
• DemyttenaereKEnzlinPDeweWCompliance with antidepres-sants in a primary care setting, 2: the influence of gender and type of impairmentJ Clin Psychiatry200162Suppl 22S34S37
   PubMed Web of Science ®Google Scholar
• DemyttenaereKBonnewynABruffaertsRClinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)J Affect Disord2008110849318329721
   PubMed Web of Science ®Google Scholar
• LinEHVon KorffMLudmanEJEnhancing adherence to prevent depression relapse in primary careGen Hosp Psychiatry20032530331012972220
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296131011558866
   PubMed Web of Science ®Google Scholar
• PompiliMSerafiniGDel CasaleAImproving adherence in mood disorders: the struggle against relapse, recurrence and suicide riskExpert Rev Neurother20099985100419589049
   PubMed Web of Science ®Google Scholar
• WardenDTrivediMHWisniewskiSRPredictors of attrition during initial (citalopram) treatment for depression: a STAR*D reportAm J Psychiatry20071641189119717671281
   PubMed Web of Science ®Google Scholar
• NelsonJCMazureCMJatlowPIBowersMBJrPriceLHCombining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized studyBiol Psychiatry20045529630014744472
   PubMed Web of Science ®Google Scholar
• PapakostasGIThaseMEFavaMNelsonJCSheltonRCAre antide-pressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agentsBiol Psychiatry2007621217122717588546
   PubMed Web of Science ®Google Scholar
• BeiqueJCLavoieNde MontignyCDebonnelGAffinities of venlafaxine and various reuptake inhibitors for the serotonin and nor-epinephrine transportersEur J Pharmacol19983491291329669506
   PubMed Web of Science ®Google Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet200937374675819185342
   PubMed Web of Science ®Google Scholar
• BeiqueJCde MontignyCBlierPDebonnelGVenlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sitesSynapse19993219821110340630
   PubMed Web of Science ®Google Scholar
• Duloxetine hydrochloridePrescribing informationIndianapolis, INLilly USA LLC2009
   Google Scholar
• LiuXCChenYFariesDMinerCSwindleRImpact of comorbidities on antidepressant initiation: duloxetine, venlafaxine, and escitalopram versus other SSRIs38th American College of Clinical Pharmacology Annual Meeting2009 Sept 13–15San Antonio, TX
   Google Scholar
• CrownWHFinkelsteinSBerndtERLingThe impact of treatment-resistant depression on health care utilization and costsJ Clin Psychiatry20026396397112444808
   PubMed Web of Science ®Google Scholar
• MatzaLSRajagopalanKSThompsonCLde LissovoyGMisdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costsJ Clin Psychiatry2005661432144016420081
   PubMed Web of Science ®Google Scholar
• IosifescuDVBankierBFavaMImpact of medical comorbid disease on antidepressant treatment of major depressive disorderCurr Psychiatry Rep2004619320115142472
   PubMedGoogle Scholar
• IosifescuDVClementi-CravenNFraguasRCardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorderPsychosom Med20056770370616204427
   PubMed Web of Science ®Google Scholar
• LiuXCYeWWatsonPTepperPUse of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseasesJ Nerv Ment Dis201019854455020699718
   PubMed Web of Science ®Google Scholar
• OngJCGressJLSan Pedro-SalcedoMGManberRFrequency and predictors of obstructive sleep apnea among individuals with major depressive disorder and insomniaJ Psychosom Res20096713514119616140
   PubMed Web of Science ®Google Scholar
• SheltonCFactors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherenceCNS Spectr200914151920397587
   PubMed Web of Science ®Google Scholar
• VaccarinoALSillsTLEvansKRKalaliAHMultiple pain complaints in patients with major depressive disorderPsychosom Med20097115916219073755
   PubMed Web of Science ®Google Scholar
• WuEQGreenbergPEYangEYuAPBen-HamadiRErderMHTreatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIsJ Med Econ20091212413519566483
   PubMedGoogle Scholar
• KroenkeKKrebsEEBairMJPharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviewsGen Hosp Psychiatry20093120621919410099
   PubMed Web of Science ®Google Scholar
• YeWYZhaoYRobinsonRSwindleRPredictors of treatment initiation with duloxetine compared with venlafaxine XR among patients with major depressive disorder in US managed-care setting13th International Meeting of the International Society for Pharmacoeconomics and Outcomes Research2008 May 3–7Toronto, ON
   Google Scholar
• KarasuTBGelenbergAMerriamAEWangPAmerican Psychiatric Association practice guideline for the treatment of patients with major depressive disorderAm J Psychiatry2000157145
   Web of Science ®Google Scholar
• QaseemASnowVDenbergTDForcieaMAOwensDKUsing second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of PhysiciansAnn Intern Med200814972573319017591
   PubMed Web of Science ®Google Scholar
• SkljarevskiVZhangSChappellASWalkerDJMurrayIBackonjaMMaintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded studyPain Med20101164865720546509
   PubMed Web of Science ®Google Scholar
• GartlehnerGGaynesBNHansenRAComparative benefits and harms of second-generation antidepressants: background paper for the American College of PhysiciansAnn Intern Med200814973475019017592
   PubMed Web of Science ®Google Scholar